| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/08/2001 | EP1121369A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 08/08/2001 | EP1121362A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 08/08/2001 | EP1121360A1 Il-8 receptor antagonists |
| 08/08/2001 | EP1121359A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 08/08/2001 | EP1121358A1 Heterocyclylaminomethyloxazolidinones as antibacterials |
| 08/08/2001 | EP1121355A1 Quinoline derivatives and their use as antibacterial agents |
| 08/08/2001 | EP1121349A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 08/08/2001 | EP1121348A1 Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP1121149A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| 08/08/2001 | EP1121148A2 Immunostimulant emulsion |
| 08/08/2001 | EP1121130A2 Zinc finger-reactive antimicrobial compounds |
| 08/08/2001 | EP1121128A1 A method of modulating ion channel functional activity |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1121101A1 Aerosol ointment compositions and method of manufacture |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | EP1024792A4 Topical antifungal composition |
| 08/08/2001 | EP1011692A4 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
| 08/08/2001 | EP0824357B1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 08/08/2001 | CN1307638A Host-encoded protein expressed on Marek's disease (MDV)-infected cells and antibody thereto |
| 08/08/2001 | CN1307637A Polynucleotides isolated from skin cells and methods for their use |
| 08/08/2001 | CN1307590A Treating and diagnosing macrophage-mediated diseases using FC receptor ligands |
| 08/08/2001 | CN1307578A Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 08/08/2001 | CN1307568A Crystalline efavirenz |
| 08/08/2001 | CN1307565A Quinolones used as MRS inhibitor and bactericides |
| 08/08/2001 | CN1307487A Method of treating endotoxemia |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307000A Vaccine for hoof-and-mouth disease and preparing method thereof |
| 08/08/2001 | CN1306965A Bacteriocidal/permeation enhanced protein functional area bioactive pipetide |
| 08/08/2001 | CN1306856A Application of freyn cinquefoil herb in preparing medicine for inhibiting herpes zoster virus |
| 08/08/2001 | CN1306827A AIDS treating Chinese medicine |
| 08/08/2001 | CN1069319C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 08/08/2001 | CN1069217C Immune serum globulin for intravenous injection and preparing method thereof |
| 08/08/2001 | CN1069216C Process for production of attenuated varicella zoster virus vaccine |
| 08/08/2001 | CN1069209C Medicine powdet for tuberculosis |
| 08/08/2001 | CN1069197C Pharmaceutical formulation containing dirithromycin |
| 08/08/2001 | CN1069196C Application of rifampicin in linxiao'an medicine for treating gonorrhea |
| 08/08/2001 | CN1069195C Prep. of suspendible composition |
| 08/07/2001 | US6271383 Antibiotic oxazolidinone derivatives |
| 08/07/2001 | US6271376 Process for the preparation of N-(amino-4,6-dihalo-pyrimidine) formamides |
| 08/07/2001 | US6271373 Compounds, compositions and methods for treating influenza |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271267 Compound to regulate the morphological transition of dimorphic candida |
| 08/07/2001 | US6271250 Metal Glycididaagolc, and preparation and uses thereof |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6271222 Antibiotic |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271017 Genes of Heliciobacter pylori necessary for the regulation and maturation of urease and their use |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
| 08/07/2001 | US6270959 Human T-cell lymphotropic virus type II envelope protein and human monoclonal antibodies specific therefor |
| 08/07/2001 | US6270956 Polypeptide activator of gene expression; for use in treatment of preferential viral diseases and infections; for the detection of modulators of gene expression |
| 08/07/2001 | US6270808 Anti-viral isolates obtainable from leeches |
| 08/07/2001 | US6270800 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine |
| 08/07/2001 | US6270799 1-cyclopropyl-7-((s,s)-2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluo ro-1, 4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts |
| 08/07/2001 | US6270777 For protecting susceptible hosts against diseases caused by bacterial pathogens which secrete a zinc metalloprotease. |
| 08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
| 08/07/2001 | US6270775 Streptococcal C5a peptidase vaccine |
| 08/07/2001 | US6270770 Production losses can be prevented by a live attenuated caa vaccine for mucosal administration. |
| 08/07/2001 | US6270768 Azithromycins |
| 08/07/2001 | US6270764 Therapy for a serious and debilitating disorder while avoiding complications such as bleeding tendency, toxicity and general side effects of currently available anti-coagulant agents. |
| 08/07/2001 | US6270759 Method of using IL-11 for treating gingivitis |
| 08/07/2001 | US6270755 Anionic polymers as toxin binders |
| 08/07/2001 | CA2211006C Topically applied pharmaceutical composition, method of preparing it and its use |
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/07/2001 | CA2104782C 1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines |
| 08/07/2001 | CA2044746C Polypeptide compound and a process for preparation thereof |
| 08/02/2001 | WO2001055396A1 NOVEL POLYPEPTIDES HmrA AND HmrB |
| 08/02/2001 | WO2001055357A2 Myeloid colony stimulating factor and uses thereof |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055353A2 Recombinant attenuation of prrsv |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055330A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | WO2001055217A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
| 08/02/2001 | WO2001055177A2 Methods to identify ctl epitopes of hiv |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001055155A1 Novel carbapenem derivatives of quaternary salt type |
| 08/02/2001 | WO2001055154A1 Novel carbapenem derivatives |
| 08/02/2001 | WO2001055153A1 Clavams as protease inhibitors |
| 08/02/2001 | WO2001055131A2 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
| 08/02/2001 | WO2001054771A2 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054720A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | WO2001054719A2 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 08/02/2001 | WO2001054718A2 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions |
| 08/02/2001 | WO2001054714A1 Method for regulating il-10 with il-9, and applications thereof |
| 08/02/2001 | WO2001054704A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 08/02/2001 | WO2001054703A1 Antifungal drug composition and drug delivery system |
| 08/02/2001 | WO2001054693A1 Use of thiostrepton as an anti-mycobacterial agent |
| 08/02/2001 | WO2001054692A1 Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections |
| 08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | WO2001054680A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054675A2 Pharmaceutical compositions comprising terbinafine |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001054481A2 Enhanced propertied pharmaceuticals |
| 08/02/2001 | WO2001016114A3 Heterocyclic compounds and methods for modulating cxcr3 function |